GBT 440-038 - An Open-Label Extension Study of Voxelotor Administered Orally to Pediatric Participants with Sickle Cell Disease Who Have Participatedin Voxelotor Clinical Trials

Project: Research project

Project Details

StatusActive
Effective start/end date1/2/20 → 8/31/50

Funding

  • Global Blood Therapeutics, Inc.